These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 10184748)

  • 1. Clinical considerations in GERD (gastroesophageal reflux disease) therapy: focus on cisapride.
    Snape WJ
    Am J Manag Care; 1997 May; 3(5):766-71. PubMed ID: 10184748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ
    J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prokinetic therapy in gastroesophageal reflux disease.
    Champion MC
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():55B-65B. PubMed ID: 9347180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroesophageal reflux in infants and children.
    Jung AD
    Am Fam Physician; 2001 Dec; 64(11):1853-60. PubMed ID: 11764863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualized acute treatment strategies for gastroesophageal reflux disease.
    Reynolds JC
    Scand J Gastroenterol Suppl; 1995; 213():17-24. PubMed ID: 8578239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacological management of gastroesophageal reflux disease.
    Lowe RC; Wolfe MM
    Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group.
    Castell DO; Sigmund C; Patterson D; Lambert R; Hasner D; Clyde C; Zeldis JB
    Am J Gastroenterol; 1998 Apr; 93(4):547-52. PubMed ID: 9576446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prokinetic therapy for gastroesophageal reflux disease.
    Robinson M
    Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical therapy of extraesophageal gastroesophageal reflux disease.
    Katz PO
    J Clin Gastroenterol; 2000 Apr; 30(3 Suppl):S42-4. PubMed ID: 10777172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management of gastroesophageal reflux disease.
    DeVault KR
    Gastroenterologist; 1996 Mar; 4(1):24-32. PubMed ID: 8689142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroesophageal reflux disease: diagnosis and management.
    Scott M; Gelhot AR
    Am Fam Physician; 1999 Mar; 59(5):1161-9, 1199. PubMed ID: 10088873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new prokinetic drug cisapride: pharmacological properties and clinical potential].
    Sheptulin AA; Muradov NN
    Klin Med (Mosk); 1997; 75(7):53-6. PubMed ID: 9411058
    [No Abstract]   [Full Text] [Related]  

  • 14. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ; Hunt RH
    Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary medical therapy for gastroesophageal reflux disease.
    Fass R; Hixson LJ; Ciccolo ML; Gordon P; Hunter G; Rappaport W
    Am Fam Physician; 1997 Jan; 55(1):205-12, 217-8. PubMed ID: 9012279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease.
    Arabehety JT; Leitão OR; Fassler S; Olarte M; Serrano C
    Clin Ther; 1988; 10(4):421-8. PubMed ID: 3079010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging drugs for gastroesophageal reflux disease.
    Boeckxstaens GE
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency scale symptoms for gastroesophageal reflux disease (Frequency Scale for Symptoms of GERD) predicts need for addition of prokinetics to proton pump inhibitor therapy.
    Nandurkar S
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1165-7. PubMed ID: 18699977
    [No Abstract]   [Full Text] [Related]  

  • 19. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
    Halter F; Staub P; Hammer B; Guyot J; Miazza BM
    J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease.
    Hatlebakk JG; Johnsson F; Vilien M; Carling L; Wetterhus S; Thøgersen T
    Scand J Gastroenterol; 1997 Nov; 32(11):1100-6. PubMed ID: 9399390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.